After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$1.61M

Walsh Colin Director

Transaction date Aug 5, 2026
Public filing date Aug 13, 2026
Filing lag Filed 8 days later

ATTO daily price context

No linked price history

This asset is not matched to a market-data symbol.

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
76,418 shares @ $21.04
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001866174-26-000009
Filing cohort

Transactions in this filing

Showing 15 of 29
Trades
29
Issuers
1
Estimated value
$12.54M
Buys / sales
2 / 23
Transactions reported in the same official filing
Issuer Transaction Traded Value
Attovia Therapeutics, Inc. ATTO Conversion Aug 6, 2026 $0
Attovia Therapeutics, Inc. ATTO Conversion Aug 6, 2026 $0
Attovia Therapeutics, Inc. ATTO Conversion Aug 6, 2026 $0
Attovia Therapeutics, Inc. ATTO Conversion Aug 6, 2026 $0
Attovia Therapeutics, Inc. ATTO Buy Aug 6, 2026 $8.5M
Attovia Therapeutics, Inc. ATTO Buy Aug 5, 2026 $1.78M
Attovia Therapeutics, Inc. ATTO Sale Aug 5, 2026 $15.45K
Attovia Therapeutics, Inc. ATTO Sale Aug 5, 2026 $4.41K
Attovia Therapeutics, Inc. ATTO Sale Aug 5, 2026 $34.33K
Attovia Therapeutics, Inc. ATTO Sale Aug 5, 2026 $25.81K
Attovia Therapeutics, Inc. ATTO Sale Aug 5, 2026 $153.55K
Attovia Therapeutics, Inc. ATTO Sale Aug 5, 2026 $4.41K
Attovia Therapeutics, Inc. ATTO Sale Aug 5, 2026 $146.15K
Attovia Therapeutics, Inc. ATTO Sale Aug 5, 2026 $29.34K
Attovia Therapeutics, Inc. ATTO Sale Aug 5, 2026 $74.91K